TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 26885782

Group type: EXPERIMENTAL
Intervention: DFD-01
Number of subjects: 351

Group type: COMPARATOR
Intervention: Diprolene
Number of subjects: 351

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 351
Study: 24344086

Group type: EXPERIMENTAL
Intervention: Dabigatran 150 mg twice daily
Number of subjects: 2589

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 2589

Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 2589
Study: 22143619

Group type: EXPERIMENTAL
Intervention: Familias cash transfer program
Number of subjects: 2073

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2073

Group type: EXPERIMENTAL
Intervention: Household wealth
Number of subjects: 2073
Study: 19875087

Group type: EXPERIMENTAL
Intervention: Pegaptanib 0.3 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Pegaptanib 1 mg
Number of subjects: 20
Study: 17620136

Group type: EXPERIMENTAL
Intervention: Pectoralis minor length test
Number of subjects: 90
Study: 16181934

Group type: EXPERIMENTAL
Intervention: BCAA supplementation (19.6g/d)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 11939381

Group type: EXPERIMENTAL
Intervention: Primary health care liaison worker (PHCLW) services
Number of subjects: 155

Group type: COMPARATOR
Intervention: Standard support from the community drug team (CDT)
Number of subjects: 155
Study: 10516703

Group type: EXPERIMENTAL
Intervention: Atovaquone (1500 mg daily from transplant day -5 to day -1, then 3 days per week until day +100)
Number of subjects: 39

Group type: COMPARATOR
Intervention: TMP/SMX (160/800 mg daily from transplant day -5 to day -1, then 3 days per week until day +100)
Number of subjects: 39
Study: 7726804

Group type: EXPERIMENTAL
Intervention: Behavioural group treatment
Number of subjects: 24

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 24
Study: 2402122

Group type: EXPERIMENTAL
Intervention: 5% NaCl infusion (6 mEq per kg body wt for 120 minutes)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 2.5% NaCl infusion (6 mEq per kg body wt for 120 minutes)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 5% NaCl infusion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Desoxycorticosterone acetate (DOCA; 20 mg i.m. for three days) before saline (5%) infusion
Number of subjects: 10
Study: 31997794

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma therapy with total contact casting (Group A)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Total contact casting alone (Group B)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Paucibacillary leprosy patients
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Patients with lower initial surface area of the ulcer
Number of subjects: 118
Study: 30940833

Group type: EXPERIMENTAL
Intervention: FOS at 2.5 g/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: FOS at 5 g/day
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: FOS at 10 g/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (Maltodextrin 10 g/day)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: FOS (all doses)
Number of subjects: 80
Study: 27910708

Group type: EXPERIMENTAL
Intervention: Myo-inositol (2 g twice a day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Myo-inositol (2 g/d) plus melatonin (3 g/d before sleeping)
Number of subjects: 40
Study: 26121625

Group type: EXPERIMENTAL
Intervention: Remote Follow-up (RF)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Hospital Follow-up (HF)
Number of subjects: 83
Study: 22419416

Group type: EXPERIMENTAL
Intervention: Self-efficacy levels in the top three quintiles
Number of subjects: 221
Study: 22448804

Group type: EXPERIMENTAL
Intervention: Adjunctive emotion regulation group therapy (ERGT) for 14 weeks
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Adjunctive emotion regulation group therapy (ERGT)
Number of subjects: 23
Study: 19268732

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 314

Group type: COMPARATOR
Intervention: Tirofiban
Number of subjects: 314
Study: 17206289

Group type: EXPERIMENTAL
Intervention: Aprotinin (0.5 million KIU infused before and during cardiopulmonary bypass)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Placebo (100 ml normal saline infused before and during cardiopulmonary bypass)
Number of subjects: 162

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 162
Study: 15742795

Group type: EXPERIMENTAL
Intervention: Child behavior problems
Number of subjects: 69
Study: 11555157

Group type: EXPERIMENTAL
Intervention: Levamisole and/or Chinese medicinal herbs
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combination therapy with levamisole plus Chinese medicinal herbs
Number of subjects: 43

Group type: COMPARATOR
Intervention: Levamisole only
Number of subjects: 43

Group type: COMPARATOR
Intervention: Chinese medicinal herbs only
Number of subjects: 43

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 43
Study: 9661860

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.0625‐0.25%)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.0625‐0.25%) + Fentanyl (2‐10 micrograms)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Both groups (Bupivacaine and Bupivacaine + Fentanyl)
Number of subjects: 87
Study: 7923458

Group type: EXPERIMENTAL
Intervention: Nifedipine 30 to 90 mg/day
Number of subjects: 126

Group type: COMPARATOR
Intervention: Methyldopa 750 to 2000 mg/day
Number of subjects: 126
Study: 3044642

Group type: EXPERIMENTAL
Intervention: Surgical group
Number of subjects: 68

Group type: COMPARATOR
Intervention: Medical group
Number of subjects: 68
Study: 30130297

Group type: EXPERIMENTAL
Intervention: Placebo cream with information that it would reduce pain
Number of subjects: 296

Group type: COMPARATOR
Intervention: Natural history group receiving pain stimuli without any application of cream or manipulation of expectation
Number of subjects: 296
Study: 28202745

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Etanercept (ETN)
Number of subjects: 22
Study: 25513971

Group type: EXPERIMENTAL
Intervention: Metacognitive training (MCT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 80
Study: 23553549

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion 150 mEq/L in 5% dextrose solution
Number of subjects: 92

Group type: COMPARATOR
Intervention: 0.9% sodium chloride 154 mEq/L infusion
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion
Number of subjects: 92

Group type: COMPARATOR
Intervention: Sodium chloride infusion
Number of subjects: 92
Study: 20090541

Group type: EXPERIMENTAL
Intervention: 1 mg kg(‐1) hydroxyzine hydrochloride suspension (Atarax) 1 h preoperatively (group I, n=15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 0.7 mg kg(‐1) midazolam (Dormicum) 15 min preoperatively (group II, n=15)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 3 mg kg(‐1) ketamine (Ketalar) with 0.25 mg kg(‐1) midazolam (Dormicum) 15 min preoperatively (group III, n=15)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No oral premedication administration (group IV, controls, n=15)
Number of subjects: 60
Study: 19047540

Group type: EXPERIMENTAL
Intervention: Teacher training in classroom instruction and management, child social and emotional skill development, and parent workshops
Number of subjects: 598

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 598
Study: 17180512

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT) with weekly carboplatin or low daily dose of cisplatin
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Salvage surgery after CRT
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CRT)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Neck dissection (ND) after CRT
Number of subjects: 63
Study: 14649345

Group type: EXPERIMENTAL
Intervention: Adenosine 80 microg kg min infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (control) infusion
Number of subjects: 60
Study: 11324989

Group type: EXPERIMENTAL
Intervention: levodopa/carbidopa
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: bromocriptine
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: selegiline
Number of subjects: 58

Group type: COMPARATOR
Intervention: healthy controls
Number of subjects: 58
Study: 8780077

Group type: EXPERIMENTAL
Intervention: Divalproex sodium
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 1395210

Group type: EXPERIMENTAL
Intervention: Ventricular arrhythmias in CHF patients, including ambient ventricular premature complexes and nonsustained ventricular tachycardia on a 24‐h Holter recording.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low left ventricular ejection fraction (LVEF) predicting inducible sustained ventricular tachycardia on electrophysiologic study.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New York Heart Association (NYHA) Functional Class worsening.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall yearly mortality in CHF patients.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Causes of death in CHF patients.
Number of subjects: 0
Study: 6487508

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol (conventional therapeutic doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29772387

Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire Summary Score (SAQ SS)
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire Physical Limitation (SAQ PL) scale
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire Anginal Stability (SAQ AS) scores
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire Angina Frequency (SAQ AF) scale
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: Seattle Angina Questionnaire Quality of Life (SAQ QoL) scores
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: SAQ scales
Number of subjects: 4013

Group type: EXPERIMENTAL
Intervention: SAQ SS
Number of subjects: 4013
Study: 27314365

Group type: EXPERIMENTAL
Intervention: Healthy Elderly (HE)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Alzheimer's Disease (AD)
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Mild Cognitive Impairment (MCI)
Number of subjects: 305
Study: 25198487

Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: No music therapy (Control)
Number of subjects: 70
Study: 22718152

Group type: EXPERIMENTAL
Intervention: Topical bromfenac
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 38
Study: 20094704

Group type: EXPERIMENTAL
Intervention: Pilates exercise program
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) program
Number of subjects: 62
Study: 18655740

Group type: EXPERIMENTAL
Intervention: Maximal inspiration with thoracic support
Number of subjects: 21

Group type: COMPARATOR
Intervention: Thoracic support alone
Number of subjects: 21

Group type: COMPARATOR
Intervention: Different cough conditions
Number of subjects: 21

Group type: COMPARATOR
Intervention: First day versus second measurement day
Number of subjects: 21
Study: 15853110

Group type: EXPERIMENTAL
Intervention: Group 1: Cavity conditioner and Fuji II LC (GC America)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group 2: Prime & Bond NT and Dyract Flow (Caulk‐Dentsply)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Group 3: Excite and Tetric flow (Ivoclar/Vivadent)
Number of subjects: 36
Study: 12459926

Group type: EXPERIMENTAL
Intervention: Risperidone 0.25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Risperidone 0.5 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lorazepam 1 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 10514777

Group type: COMPARATOR
Intervention: Propofol without additives
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Propofol with 20 mg of lidocaine
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Propofol with 40 mg of lidocaine
Number of subjects: 3
Study: 8673684

Group type: EXPERIMENTAL
Intervention: Ebastine 20 mg
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Ebastine 10 mg
Number of subjects: 343

Group type: EXPERIMENTAL
Intervention: Cetirizine 10 mg
Number of subjects: 343
Study: 1932611

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 5 mg benzydamine
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral administration of benzydamine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Mouthwash application of benzydamine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Dermal cream application of benzydamine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Vaginal douche application of benzydamine
Number of subjects: 6
Study: 6588267

Group type: EXPERIMENTAL
Intervention: Exercise training (3 to 5 times weekly for a mean of 12 +/- 4 months)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sedentary control
Number of subjects: 25
Study: 31247033

Group type: EXPERIMENTAL
Intervention: Positive emotions reporting
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Negative emotions reporting
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Non-emotional internal states reporting
Number of subjects: 90

Group type: COMPARATOR
Intervention: All groups
Number of subjects: 90
Study: 29231343

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding combined with auricular point pressure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Nilestriol (1 mg once a day) combined with oryzanol (20 mg three times per day)
Number of subjects: 60
Study: 26493557

Group type: EXPERIMENTAL
Intervention: PP‐501‐A‐Lidocaine
Number of subjects: 66

Group type: COMPARATOR
Intervention: RestylaneLidocaine(®)
Number of subjects: 66
Study: 24169335

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (25 mg/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (50 mg/kg)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (75 mg/kg)
Number of subjects: 50

Group type: COMPARATOR
Intervention: IL‐13 control (10 µg/L IL‐13 + physiological saline)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Negative control (physiological saline)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (25 µmol/L)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (50 µmol/L)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (75 µmol/L)
Number of subjects: 50
Study: 21840502

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM) procedure inducing bias toward negative material
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM) procedure inducing bias toward positive material
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (high-expression 5-HTTLPR gene)
Number of subjects: 116
Study: 18653640

Group type: EXPERIMENTAL
Intervention: Measles vaccination using standard titre Edmonston‐Zagreb vaccine at 4.5 months of age
Number of subjects: 1333

Group type: COMPARATOR
Intervention: Control group (unvaccinated)
Number of subjects: 1333

Group type: EXPERIMENTAL
Intervention: Treatment group (vaccinated)
Number of subjects: 1333
Study: 16868892

Group type: EXPERIMENTAL
Intervention: 1.5 or 3.0 mg dexamethasone (DEX) per os at 09:00 or 21:00 hours
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 15305654

Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 138

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 138

Group type: COMPARATOR
Intervention: Surgery only group
Number of subjects: 138
Study: 11718195

Group type: EXPERIMENTAL
Intervention: Plated group
Number of subjects: 50

Group type: COMPARATOR
Intervention: Non-plated group
Number of subjects: 50
Study: 9150772

Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion of fentanyl (2 micrograms/ml) and bupivacaine (1.0 mg/ml) at a rate of 0.25 ml.kg‐1.h‐1
Number of subjects: 31

Group type: COMPARATOR
Intervention: Intermittent epidural morphine (30 micrograms/kg every 8 h)
Number of subjects: 31
Study: 7957516

Group type: EXPERIMENTAL
Intervention: Sublingual spray (2.5 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sublingual tablet (5 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Peroral tablet (10 mg)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All formulations
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Haemodynamic effects
Number of subjects: 16
Study: 3821226

Group type: EXPERIMENTAL
Intervention: Printed educational materials and face-to-face visits by clinical pharmacists (experimental group)
Number of subjects: 435

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Follow-up reinforcement visit (experimental group)
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Total exposure time (experimental group)
Number of subjects: 435
Study: 29634648

Group type: EXPERIMENTAL
Intervention: Lifestyle exercise (≥130 hours/year)
Number of subjects: 116
Study: 27109456

Group type: COMPARATOR
Intervention: Plastic stents
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: FCSEMSs
Number of subjects: 86
Study: 24583059

Group type: EXPERIMENTAL
Intervention: ALV003
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 23369765

Group type: EXPERIMENTAL
Intervention: Group-based adaptation of the Diabetes Prevention Program lifestyle intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health care-community partnership
Number of subjects: 0
Study: 21457065

Group type: EXPERIMENTAL
Intervention: Pioglitazone + Metformin (PM)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Metformin + Glimepiride (GM)
Number of subjects: 288
Study: 18339222

Group type: EXPERIMENTAL
Intervention: DHA-rich tuna fish oil (6 g fish oil/d, DHA 1.56 g/d, EPA 0.36 g/d)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sunflower-seed oil (placebo)
Number of subjects: 65
Study: 16545929

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4)) 250 mg/kg intravenous solution
Number of subjects: 47

Group type: COMPARATOR
Intervention: Isotonic saline (0.9%)
Number of subjects: 47
Study: 12702620

Group type: EXPERIMENTAL
Intervention: Behavioural counselling
Number of subjects: 271

Group type: COMPARATOR
Intervention: Nutrition education counselling
Number of subjects: 271
Study: 11094664

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg intravenously
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 8883683

Group type: EXPERIMENTAL
Intervention: Cooling pad applied to the knee postoperatively set at 40 to 50 degrees F
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cooling pad applied to the knee postoperatively set at 70 to 80 degrees F
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ice packs
Number of subjects: 0

Group type: COMPARATOR
Intervention: No cold therapy
Number of subjects: 0
Study: 1407495

Group type: EXPERIMENTAL
Intervention: Closed head injury patients with brain lesions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Patients with posterior cerebral excisions (mainly for tumours)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CHI patients with non-frontal parenchymal lesions
Number of subjects: 0
Study: 3768778

Group type: EXPERIMENTAL
Intervention: Dye cardiac output measurement at rest
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Fick cardiac output measurement at rest
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Dye cardiac output measurement during exercise
Number of subjects: 1022

Group type: EXPERIMENTAL
Intervention: Fick cardiac output measurement during exercise
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Comparison of Fick and dye methods
Number of subjects: 1022
Study: 29564722

Group type: EXPERIMENTAL
Intervention: Pixantrone monotherapy
Number of subjects: 140
Study: 26277862

Group type: EXPERIMENTAL
Intervention: PVAI alone (group 1)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: PVAI + LAPW isolation (group 2)
Number of subjects: 52
Study: 25231836

Group type: EXPERIMENTAL
Intervention: Metabolically healthy patients
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Metabolically abnormal patients
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Metabolically abnormal subjects
Number of subjects: 1002
Study: 22938914

Group type: EXPERIMENTAL
Intervention: PM (physician management)
Number of subjects: 47

Group type: COMPARATOR
Intervention: PM+EMM (physician management plus enhanced medical management)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study: 20035207

Group type: EXPERIMENTAL
Intervention: HibMenCY‐TT
Number of subjects: 609

Group type: COMPARATOR
Intervention: MPSV4
Number of subjects: 609

Group type: COMPARATOR
Intervention: Hib‐TT
Number of subjects: 609
Study: 18777125

Group type: EXPERIMENTAL
Intervention: Bilateral peritoneal fenestration (Group A, n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No peritoneal incisions (Group B, n = 50)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Bilateral peritoneal fenestration (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: No peritoneal incisions (Group B)
Number of subjects: 100
Study: 17152731

Group type: EXPERIMENTAL
Intervention: Thymomimetic Vilon (Lys‐Glu) administration
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment for DM‐1 patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thymomimetic Vilon (Lys‐Glu) in elderly patients with severe DM‐1
Number of subjects: 0
Study: 14974912

Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (3.75 mg intramuscularly) plus tibolone (2.5 mg/day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Leuprolide acetate (3.75 mg intramuscularly) plus placebo
Number of subjects: 28
Study: 11881696

Group type: EXPERIMENTAL
Intervention: Individual performance feedback intervention provided to nurses
Number of subjects: 240
Study: 8706769

Group type: EXPERIMENTAL
Intervention: Levosimendan 1 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Levosimendan 2 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Captopril (50 mg b.i.d.) with levosimendan
Number of subjects: 24
Study: 1404674

Group type: EXPERIMENTAL
Intervention: Color Doppler Imaging (CDI)
Number of subjects: 29